Nasdaq

Invitae Announces Partnership for Real-World Data Sharing to Inform Rare Cancer Research

– Using Invitae's Ciitizen patient-driven data platform, AstraZeneca and the Cholangiocarcinoma Foundation will access lived experience of patients with a rare cancer to drive further research – – ...
Business Wire

Invitae Announces Major Expansion of Its Test Menu for Neurological, Pediatric, and Rare Genetic Conditions and Introduces New Panels for Inherited Metabolic Disorders and ...

SAN FRANCISCO--(BUSINESS WIRE)--Invitae Corporation (NYSE:NVTA), a genetic information company, today announced that it has expanded its genetic testing offering with hundreds of additional genes and ...
Seeking Alpha

Invitae to Present Data at the National Society of Genetic Counselors 42nd Annual Conference That Supports Advancements in Medical Genomics

- These studies combined with new digital tools aim to increase access and frequency of hereditary cancer screening both before and during treatment - SAN FRANCISCO, Oct. 10, 2023 /PRNewswire/ -- ...
Business Wire

Invitae Introduces New Breast Cancer STAT Panel for Patients With Breast Cancer Who Need Rapid Test Results to Guide Surgical Decisions

SAN FRANCISCO--(BUSINESS WIRE)--Invitae Corporation (NYSE: NVTA), a genetic information company, today announced that the company now offers a new Breast Cancer STAT Panel of high-quality genetic ...
Becker's Hospital Review

Invitae, research program partner for data sharing

Medical genetics company Invitae is partnering with research program Simons Searchlight to analyze rare genetic neurodevelopmental disorders through data sharing. Invitae will share its longitudinal ...